Haleon (HLNCF) Curent Deferred Tax Liability (2022 - 2023)
Haleon (HLNCF) recorded quarterly Curent Deferred Tax Liability of $39.5 million in Q4 2023, down 9.05% on a QoQ basis from $43.4 million in Q4 2022, and down 9.05% year-over-year from $43.4 million in Q4 2022.
Haleon (HLNCF) Curent Deferred Tax Liability (2022 - 2023) Analysis & Trends
Haleon has disclosed Curent Deferred Tax Liability across 2 years of filings, most recently posting $39.5 million for Q4 2023.
- Quarterly Curent Deferred Tax Liability fell 9.05% year-over-year to $39.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $39.5 million (down 9.05% YoY) and the FY2023 annual result came in at $39.6 million, down 13.62% from the prior year.
- Curent Deferred Tax Liability slipped to $39.5 million in Q4 2023, from $43.4 million in the prior quarter.
- Over five years, Curent Deferred Tax Liability peaked at $43.4 million in Q4 2022 and troughed at $39.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Haleon | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 39.47 Mn |
| Dec 31, 2023 | 39.47 Mn |
| Dec 31, 2022 | 43.40 Mn |
| Dec 31, 2022 | 43.40 Mn |